Endoscopic observations as a tool to define underlying pathology in kidney stone formers by Pless, Maria Sloth et al.
Vol.:(0123456789) 
World Journal of Urology (2019) 37:2207–2215 
https://doi.org/10.1007/s00345-018-02616-3
ORIGINAL ARTICLE
Endoscopic observations as a tool to define underlying pathology 
in kidney stone formers
Maria Sloth Pless1 · James Caldwell Williams Jr.2 · Kim Hovgaard Andreassen1,3 · Helene Ulrich Jung1,3 · 
Susanne Sloth Osther3 · Dorte Ravnsmed Christensen3 · Palle Jörn Sloth Osther1,3 
Received: 2 November 2018 / Accepted: 23 December 2018 / Published online: 4 January 2019 
© The Author(s) 2019
Abstract
Purpose Advancements in endoscopy offer the possibility of inspection of intrarenal anatomy and pathology. The aim of 
the study was to evaluate renal papillary appearance in kidney stone formers and to correlate papillary findings with stone 
type and patient metabolic data.
Materials and methods A consecutive cohort of 46 kidney stone formers undergoing retrograde intrarenal surgery was 
enrolled. During surgery, renal papillae were characterized in the domains of ductal Plugging (DP), surface Pitting, Loss of 
papillary contour, and Amount of Randall’s plaque (RP, PPLA scoring). Stone material was analyzed using micro-CT and 
infrared spectroscopy, and blood and urine were collected for metabolic evaluation.
Results In all patients, renal papillae had changes in at least one of the domains of the PPLA score. Examining the total 
population, it was evident that patients with predominantly plugging (DP > 0) all had very low RP scores. There were no 
significant trends between mean PPLA scores and urinary analytes for the total group.
Conclusion Efforts to prevent renal stone formation have so far been insufficient in majority of patients. Digital endoscopy 
reveals that kidney stone formers have different and distinct papillary morphologies that seem to be linked to specific stone-
forming pathways. Since renal papillary abnormalities may be easily identified during endoscopy, this may in the future 
prove to be an important method for tailoring prevention strategies in kidney stone patients.
Keywords Kidney calculi · Papillae · Ureterorenoscopy · Randall’s plaque · Pathology · Micro-computerized tomography
Introduction
Nephrolithiasis is a common disease throughout the world; 
the lifetime risk of developing kidney stones in Europe and 
USA is estimated to be 10–15% [1, 2] and kidney stone dis-
ease represents a major burden to quality of life [3].
Eight decades ago, Alexander Randall proposed sub-
epithelial calcium phosphate deposits at the tip of the renal 
papillae as the origin of renal calculi [4]. His findings were 
not adequately recognized as an important step forward in 
our understanding of the pathogenesis of renal stone forma-
tion, until recent research using modern investigational tools 
brought the unique findings into further perspective [5, 6]. 
It is now widely accepted that some kidney stones develop 
attached to sub-epithelial plaques of calcium phosphate crys-
tals (Randall’s plaques) [7]. Other stones form as a result of 
occlusion of the openings of the ducts of Bellini by stone-
forming crystals (ductal plugs) [5]. These plaques and plugs 
eventually extrude into the urinary space, acting as nidi for 
crystal overgrowth (i.e., calcium oxalate,  CaOx) and stone 
formation [8]. Randall’s plaques begin as deposits of apatite 
in the basement membranes of the thin limbs of Henle’s loop 
and can grow to become extensive deposits in the interstitial 
space beneath the epithelium covering the papillary surface 
[5, 9]. The fraction of the papilla surface that is covered with 
Randall’s plaque correlates with number of stone episodes 
and calcium excretion in the individual stone patient [10, 
11]. These findings seem to be unique for those patients 
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forming stones on RP, whereas other histopathological find-
ings with intratubular crystals have been identified as unique 
for stone formers with other types of stone diseases [12, 13]. 
The exact mechanisms by which these histopathological and 
ultrastructural changes occur remain unclear.
Technologic advancements in digital endoscopy offer 
the possibility of detailed inspection of intrarenal anatomy 
and pathology [14]. Recently, attention has been drawn to 
the relation between distinct renal papillary abnormalities 
visualized during endoscopy and unique pathogenetic path-
ways of stone formation [15–17]. The aim of the present 
study was to evaluate renal papillary appearance in a con-
secutive cohort of kidney stone formers undergoing retro-
grade intrarenal stone surgery (RIRS) using digital flexible 
ureteroscopes and to correlate the papillary findings with 
stone type and patient metabolic data to explore the role of 
endoscopic papillary findings in defining underlying stone-
forming mechanisms and clinical outcomes.
Methods
Ethics
The study was approved by the Scientific Ethical Committee 
of the Region of Southern Denmark (ID: S-20162000-2,) 
and the Danish Data Protection Agency. Apart from visual 
mapping of the renal papillae, the endoscopic procedure for 
stone management (RIRS) did not differ from standard surgi-
cal routine. Therefore, informed consent was waived.
Patients
In the period February to July 2016, patients aged 18 years 
or above with renal stones admitted for RIRS at Lille-
baelt Hospital, Denmark were consecutively included in 
the study. Characteristics of the patients are presented in 
Table 1. Inclusion criteria consisted of standard indications 
for performing RIRS. Thus, included stone patients were not 
selected according to the suspicion of specific underlying 
stone diseases and, thus, represented an unselected cohort 
of kidney stone formers.
Blood and urine samples
All patients routinely provided 24-h urines (24-h) on unre-
stricted diet before surgery or a minimum of 8 weeks later. 
No patients were on medications for stone prevention. On 
the day of surgery, a routine blood sample was drawn and 
fasting morning spot urine was collected for immediate pH 
measurement. Blood samples were analyzed for plasma cre-
atinine, uric acid, sodium, potassium, ionized calcium, bicar-
bonate and phosphate. The 24-h urine sample was analyzed 
for volume, citrate, oxalate, calcium and creatinine using 
standard laboratory methods.
Stone analysis
Stones collected during surgery were routinely analyzed 
using Fourier-transform infrared spectroscopy (IR) at the 
laboratory of Aalborg University Hospital, Denmark. Addi-
tional stone samples were obtained from most patients and 
were analyzed using both IR and micro-CT to obtain stone 
morphological details. Micro-CT was performed on speci-
mens in vitro, using a Skyscan 1172 system [18]. Scans uti-
lized 60 kV with a 0.5 mm Al filter, rotating the specimen 
0.7° for each X-ray image. Reconstruction voxel size was 
4.8 μm for images shown.
Endoscopic grading of renal papillary appearance
The PPLA scoring system (Table 2) was used for endo-
scopic grading of renal papillary findings. Details on the 
scoring system have recently been published by Borofsky 
et al. [14]. The PPLA system—grading papillary appear-
ance in the domains of ductal plugging (DP), surface 
pitting (SP), loss of contour (LC) and Randall’s plaque 
(RP)—was designed to simplify the description of papillae 
during endoscopy as a clinical and research tool to explore 
the significance of papillary pathology in stone formation. 
The different papillary pathologies are presented in Figs. 1 
and 2 and further detailed in Table 2. All lesions except 
RP are thought to represent different degrees of nephron 
loss [14]. In the present study, the original PPLA grading 
score was modified using numerical values for RP scoring 
in line with the other domains as suggested by Cohen et al. 
[17]. Each papilla was scored in all domains according 
to Table 2 and a final PPLA score for each papilla was 
calculated. After identifying and assigning scores to all 
accessible papillae within the renal unit, a mean PPLA 
score was calculated by dividing the sum of papilla scores 
by the number of papillae examined. In addition, the low-
est and the highest scores are presented to denote range of 
Table 1  Characteristics of patients included
Values are means (ranges) and absolute numbers (gender)
BMI body mass index
Clinical characteristics No patients [n = 46 (range)]
Age 54 (20–84)
BMI 27.5 (18.6–47.9)
Male 20
Female 26
Years with stone disease 6.4 (0–50)
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pathology encountered. Patients with medullary sponge 
kidney (MSK) were considered separately, as they are rec-
ognized as having a unique stone pathogenesis unlike other 
common stone-forming conditions [19].
Two kinds of digital ureterorenoscopes were used: Storz 
Flex XC (Karl Storz Endoskope, Tütlingen, Germany) 
and Olympus URF-V2 (Olympus, Hamburg, Germany). 
The location of each papilla was determined using fluor-
oscopy with contrast instillation through the ureteroscope. 
The papillae were systematically evaluated and videotaped 
during flexible ureteroscopy after stone material had been 
removed.
Image analysis
Representative still images of each papilla were captured 
from the video footage. The first author (MSP) initially 
graded the papillae during all surgical procedures. MSP and 
JCW reviewed the videos and images to determine location 
and appearance of papillae for final PPLA scoring.
Statistics
Statistical analyses were performed using JMP  (SAS®, Inc. 
Cary, NC, USA) and STATA 14 (STATA ® Corp., College 
Table 2  PPLA scoring system 
for grading renal papillae in 
kidney stone formers
a Plugging presents as yellow intraductal mineral deposits visualized just under the urothelial surface or 
protruding from the mouth of the dilated duct itself (Fig. 2). An empty dilated duct is also indicative of 
plugging (Fig. 2)
b Pitting shows as a crater-like focal erosion of the papillary surface that most likely represents a mechanical 
disruption due to a detached stone (Fig. 1)
c Loss of contour is characterized as progressive flattening of the papilla, and represents an advanced stage 
of papillary injury (Fig. 2)
d Randall’s plaques are characteristically white most commonly located near the tip of the papilla but with 
potential to appear anywhere on its surface (Fig. 1)
Score 0 1 2
Ductal  plugginga 0 yellow plaque 
deposits/dilated 
ducts
≤ 5 yellow 
plaque depos-
its/dilated 
ducts
> 5 yellow deposits/dilated ducts
Surface  pittingb None ≤ 25% papil-
lary surface 
involved
> 25% papillary surface involved
Loss of  contourc None Depressed Completely flattened
Amount of Randall’s  plaqued Mild Moderate Severe
Fig. 1  Examples of grades of Randall’s plaque and pitting in the 
PPLA (plugging, pitting, loss of contour, are of RP) system. a Mild 
Randall’s plaque on a perfectly normal papilla (score of 0, 0, 0, 0), 
b Moderate Randall’s plaque (RP score of 1) with a few linear white 
lines that are thought to be ductal plugs (score of 1, 0, 0, 1), c Severe 
Randall’s plaque (score of 2) which also shows surface pitting (sur-
rounded by a green line) with no plugging and normal contour (score 
of 0, 2, 0, 2). This kind of shallow surface pitting is thought to be a 
result of previous loss of stones that had grown on Randall’s plaque 
and then released [xx]
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Station TX, USA). Bivariate associations of PPLA scores 
and subscores with blood and urine parameters were initially 
evaluated using Spearman’s Rank Correlation and the Rank 
sum test. One-way analysis of variance (ANOVA) was used 
to determine whether there were any differences between 
urinary parameters and PPLA scores. All reported p val-
ues were two sided, with p < 0.05 considered statistically 
significant.
Results
Patients and stone classification
This unselected, consecutive series include 46 patients, of 
which 20 were males and 26 females (Table 1). Based on IR 
and micro-CT, patients were classified as calcium oxalate 
 (CaOx) stone formers if their stones contained > 50%  CaOx 
monohydrate (COM),  CaOx dihydrate (COD) or a combi-
nation of COM/COD. Patients with > 50% apatite in their 
stones were classified as apatite stone formers. Patients with 
stones containing any struvite were classified as such and 
patients classified as uric acid stone formers had stones con-
taining > 50% uric acid [20]. Thus, 25 patients (54%) were 
classified as  CaOx stone formers, two of which previously 
had undergone bariatric surgery; 5 were struvite stone form-
ers (11%); 5 (11%) were uric acid stone formers; and 5 (11%) 
apatite stone formers. In 4 patients, stone fragments were not 
available for analysis (9%). Based on radiologic and endo-
scopic findings, two patients (4%) had medullary sponge 
kidney (MSK) and these patients formed their own group.
Endoscopic papillary findings
In all patients, the renal papillae had changes in at least 
one of the domains of the PPLA system. In  CaOx stone 
formers, both RP (12 patients (48%)) and ductal plugs 
(DP) [9 patients (36%)] were seen with mean RP scores 
ranging from 0.13 to 1.43 and mean DP scores ranging 
from 0.13 to 0.63; thus, RP was predominant in this group. 
In 20 of 25  CaOx stone formers (80%), the renal papillae 
were seen as having some loss of papillary volume with 
LC mean score ranging from 0.13 to 2.0. Pitting of the 
papillae was seen in 6  CaOx patients with mean SP scores 
ranging from 0.10 to 1.38.
The apatite group was predominantly characterized by 
DP [3 patients (60%)] and LC (4 patients (80%)), with mean 
DP and LC scores ranging from 0.38 to 0.57 and 0.63 to 2.0, 
respectively. SP was not seen in the apatite group and only 
one patient showed any Randall’s plaque (mean patient RP 
score 0.44). One patient in this group had slightly elevated 
levels of plasma parathyroid hormone (7.9 picomol/l) and 
also showed the highest mean DP score of 0.57.
Uric acid stone formers were characterized by both RP 
(2 patients (40%)) and DP [3 patients (60%)) with mean RP 
scores ranging from 0.38 to 1.14, and mean DP scores from 
0.38 to 0.50)]. Four uric acid patients (80%) showed LC and 
2 patients (40%) showed SP with mean LC and SP scores 
from 0.63 to 2.00 and 0.07 to 0.63, respectively.
In struvite stone formers, RP was not seen and DP was 
seen in only one of the four patients (20%). However, LC 
was marked in the majority of patients (4 of 5 patients 
(80%)) with mean LC scores ranging from 1.33 to 2.00.
Fig. 2  Examples of grades of ductal plugging and loss of contour in the PPLA system. a Yellow arrowheads show dilated ducts and black arrows 
show ductal plugs. The papilla is flattened and illustrates loss of contour. b Black arrows show ductal plugs
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The 2 MSK patients had distinctive and widespread pap-
illary changes, including mild RP, extensive DP, and LC, 
confirming that these patients differ from other stone form-
ers with regard to pathology of stone formation [19].
In the total population of 46 stone formers, LC was identi-
fied in 38 patients (83%) with a total mean LC score of 1.20 
ranging from 0.13 to 2.00.
Examining the total patient series, it was evident that 
patients with predominantly plugging (DP > 0) all had very 
low RP scores (Fig. 3). Two illustrative cases of RP and DP 
stone disease, respectively, are presented in Figs. 4, 5 and 6.
Compound papilla findings
Compound papillae were not infrequent in this patient cohort 
(Fig. 7). On average, there were 7.6 ± 2.3 accessible papillae 
per patient kidney, with 24.1 ± 23.9% of the papillae being 
compound. 67% of the kidneys had at least 1 compound 
papilla.
Blood parameters
Data from the blood parameters are presented in Table 3 
according to the stone type. There were no significant dif-
ferences in the blood parameters among the 6 groups. Also 
blood analytes were not significantly correlated with PPLA 
scores.
Urine data
Data from 24-h and spot urines are presented in Table 3 
according to the stone type. Except for urine pH, there were 
no significant differences in urinary parameters between 
groups. Urine pH was significantly lower in uric acid 
stone formers (5.6 ± 0.2) compared to struvite (7.2 ± 0.2) 
(p = 0.009) and apatite (7.0 ± 0.2) (p = 0.03) stone form-
ers; and both struvite and apatite stone formers had signifi-
cantly higher urine pH than  CaOx stone formers (5.8 ± 0.1) 
(p = 0.002 and p = 0.008, respectively). The patient with 
primary hyperthyroidism had a very high excretion rate of 
calcium (17.7 mmol/day) and a high urine pH (Fig. 6).
Rank correlation with all patients in a single group failed 
to show any significant trends between mean PPLA score 
and urinary analytes (Table 3). Urinary citrate excretion in 
females did correlate inversely with total mean PPLA score 
(p < 0.05), but removal of 1 patient from the cohort (who 
had the highest mean PPLA score, of 5.25) rendered this 
relationship not significant (p = 0.07). Also, there were no 
Fig. 3  Relation between visible mineral plugging of papillary ducts 
and Randall’s plaque in subgroups of renal stone formers. CaOx cal-
cium oxalate, MSK medullary sponge kidney
Fig. 4  Micro-CT image slice from a stone that grew on Randall’s 
plaque, with photo of stone on mm paper. A 58-year-old male with 
BMI 21.7 from the  CaOx group had three stones analyzed with micro-
CT and IR; two of these showed Randall’s plaque (RP) attachment 
sites (apatite) in the stones (micro-CT), one shown here. Patient’s 
mean RP score was rather low (0.25). However, papillary endoscopic 
images showed attachment of stones to Randall’s plaque (Fig.  5), 
consistent with findings by micro-CT that stones in this patient 
developed as overgrowth on Randall’s plaque. In this patient occur-
rence of Randall’s plaques was accompanied by mild hypercalciu-
ria (8.6 mmol/24-h) and low urine pH (5.5). COM, calcium oxalate 
monohydrate; COD, calcium oxalate monohydrate
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significant correlations between the mean scores of the dif-
ferent domains of the PPLA (DP, SP, LC, and RP) and the 
measured 24-h urinary parameters.
Discussion
The present series has confirmed that renal stone formers 
do have distinct papillary changes that may be characterized 
using the domains of the PPLA scoring system: DP, SP, 
LC, and RP [14]. Pathogenesis of renal stone formation is 
apparently diverse. Three pathways of human kidney stone 
formation have recently been proposed [5, 6]. The first path-
way is overgrowth on interstitial apatite plaque (Randall’s 
plaque), which has been suggested to be the main pathway 
in idiopathic  CaOx nephrolithiasis; in the second pathway 
crystals deposit in the renal tubules as the starting point for 
renal stone formation; and the third pathway implies free 
solution crystallization as seen in patients with urinary 
stasis [6]. Our data clearly show that digital endoscopy of 
the renal collecting system has the potential to differenti-
ate among these underlying pathways. Although our series 
included a cohort of stone formers with different types of 
stone composition/stone disease, it was evident that patients 
with predominantly DP differed from patients with a high 
degree of RP, in the sense that patients with DP score > 0 
almost all had RP score close to 0 (Fig. 3), indicating dif-
ferent underlying stone pathways. These findings were not 
reflected in clear differences in urinary parameters. Hence, 
we were not able to confirm previously published data by 
Kuo et al. that urine calcium, pH and volume predict cover-
age of renal papilla by Randall’s plaque [11]. Our data are 
in line with the study of Linnes et al. [20], who also were 
not able to show a clear-cut correlation of plaque with uri-
nary factors. In contrast to our population, the series of Kuo 
et al. [11] consisted of a larger number of hypercalciurics 
with heavy plaque. Our cases clearly illustrate that hyper-
calciuria may be associated with both plaques and plugs 
(Figs. 4 and 6). Thus, from our data it seems evident that 
patients clinically defined as ‘idiopathic  CaOx stone formers’ 
Fig. 5  Endoscopic view of stones attached to the renal papilla in the 
same patient as Fig. 4
Fig. 6  Apatite stone former with hyperparathyroidism. A 45-year-old 
male with BMI 36.1 had 3 stone specimens analyzed using IR and 
micro-CT, both showing apatite. 24-h urine revealed a very high uri-
nary calcium excretion rate (17 mmol/24-h) and high urine pH (6.5). 
This patient was diagnosed with primary hyperparathyroidism with 
plasma-ionized calcium of 1.69  mmol/l and plasmaparathyroid hor-
mone (P-PTH) of 7.9 picomol/l. Papillary findings were characterized 
by ductal plugging (DP) and loss of contour (LC), with mean DP and 
LC scores of 0.57 and 1.0, respectively. No Randall’s plaque and sur-
face pitting were seen in this patient
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are not necessarily characterized by identical stone-forming 
pathways. This was also suggested in the paper of Linnes 
et al. [20]. Efforts to prevent stone formation in idiopathic 
 CaOx nephrolithiasis have so far been insufficient [21]. Pre-
vention strategies have almost exclusively been based on 
final urine studies. Since final urine data according to our 
findings do not clearly reflect a specific pathogenic pathway, 
treatment aimed at correcting abnormal urine findings thus 
may not target the cause of stone formation, explaining why 
preventive therapy is not always effective. In this perspec-
tive, phenotypic characterization of kidney stone formers 
with the aid of modern endoscopy may hold promise for a 
more individualized and effective approach to prevention.
As expected, uric acid stone formers in our series had 
acidic urine [22]. We found uric acid stone formers to 
have both RP (40%) and DP (60%), confirming previously 
reported data [16, 20]. Although the nature and pathogenesis 
of plaques and plugs among uric acid stone formers remain 
to be defined, these findings combined with the observations 
in the  CaOx group may be explained by the fact that  CaOx 
and uric acid stone formers often share common systemic 
characteristics (metabolic syndrome) [23].
In a previous study on biopsy proven MSK, it was found 
that the most likely mechanism for stone formation in MSK 
appears to be crystallization due to urinary stasis in dilated 
inner medullary collecting ducts with subsequent passage 
of ductal stones into the renal pelvis, where they serve as 
nuclei for stone formation [19]. Definitely, DP was the most 
prominent finding in our limited series of MSK patients, 
thus supporting previous findings. The MSK patients had 
a very recognizable pattern of papillary malformation dur-
ing endoscopy. The clinical phenotype of MSK is unclear 
because patients with other causes of stone formation may 
be incorrectly labeled as MSK based on radiologic image 
studies [24]. Therefore, the diagnosis of MSK maybe should 
be based on endoscopical rather than radiological findings, 
Fig. 7  Compound papilla showing areas of Randall’s plaque (RP)
Table 3  Blood and urine data (mean ± standard deviation)
Urine pH was measured in fasting spot urine
CaOx calcium oxalate, UA uric acid, MSK medullary sponge kidney, NSA no stone analysis
CaOx Apatite UA Struvite MSK NSA p value
n = 25 n = 5 n = 5 n = 5 n = 2 n = 4
Plasma
eGFR (ml/min) 78 ± 16 87 ± 5 62 ± 17 68 ± 26 90 ± 0 76 ± 16 0.1587
Creatinine (μmol/l) 83 ± 21 70 ± 9 105 ± 19 89 ± 50 63 ± 8 77 ± 11 0.2105
Urea (mmol/l) 5.8 ± 1.7 3.8 ± 0.7 6.8 ± 2.4 6.8 ± 3.5 3.8 ± 2.7 6.1 ± 0.6 0.1101
Sodium (mmol/l) 140 ± 2 141 ± 1 141 ± 2 140 ± 4 140 ± 1 142 ± 2 0.3138
Potassium (mmol/l) 4.0 ± 0.3 4.0 ± 0.4 4.1 ± 0.4 3.8 ± 0.2 3.8 ± 0.4 3.9 ± 0.3 0.6912
Ionized calcium (mmol/l) 1.35 ± 0.34 1.35 ± 0.20 1.31 ± 0.08 1.29 ± 0.09 1.25 ± – 1.33 ± 0.09 0.9968
CO2 (mmol/l) 26.9 ± 2.1 24.8 ± 3.6 26.4 ± 2.3 26.5 ± 2.1 21.5 ± – 28.3 ± 2.1 0.1308
Phosphate (mmol/l) 0.90 ± 0.19 0.89 ± 0.24 1.00 ± 0.33 1.02 ± 0.17 0.76 ± – 1.11 ± 0.16 0.4245
Urine
Volume (ml) 1686 ± 824 2538 ± 345 1679 ± 552 2158 ± 1136 1348 ± – 2656 ± 921 0.1532
pH 5.9 ± 0.7 7.0 ± 0.4 5.6 ± 0.5 7.2 ± 1.2 6.3 ± 1.1 5.9 ± 0.3 0.0017
Citrate (mmol/24-h) 2.63 ± 2.10 4.48 ± 1.51 2.35 ± 2.37 1.43 ± 1.16 0.40 ± – 3.33 ± 1.47 0.2996
Oxalate (μmol/24-h) 341 ± 326 323 ± 33 296 ± 152 373 ± 136 268 ± – 294 ± 15 0.9967
Calcium (mmol/24-h) 4.36 ± 2.90 7.82 ± 6.65 1.83 ± 0.50 4.73 ± 2.86 4.00 ± – 8.20 ± 2.84 0.0781
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which potentially may result in more homogeneous meta-
bolic findings in this unique population in the future.
Our apatite stone formers were predominantly charac-
terized by DP and only very limited RP, which was also 
the main finding in the study of Evan et al. [12]. LC was 
a characteristic finding in our apatite group, suggestive of 
advanced papillary injury in this group [14]. Our findings 
support apatite stone formation to be distinctly different 
from idiopathic  CaOx nephrolithiasis and that these patients 
may be at higher risk for developing chronic kidney disease 
[25].
The only consistent finding in the struvite group was LC, 
which may correlate to interstitial inflammation as demon-
strated in a recent study [26]. In line with our data, their 
findings suggest that RP has a limited role for struvite stone 
formation and an alternate pathogenic mechanism is thus 
implicated [26].
Strength and limitations
A strength in our analysis was that stones were classified 
with both IR and micro-CT, ensuring a high accuracy in 
characterizing stone composition [6]. A limitation was that 
stones were sampled retrogradely, meaning that the majority 
of stones were collected subsequent to laser fragmentation 
and only a subset of stones (papillary stones and smaller 
free stones that were extracted in toto) could be considered 
complete stones. This might have affected classification 
of patients. Furthermore, the relatively small heterogene-
ous patient population constitutes a limitation, although we 
attempted to control for this with a prospective, standard-
ized design. The frequency of compound papillae among the 
patients in our study likely had an effect on the measures of 
papillary properties, as there are as yet no published guide-
lines of what would constitute LC in a compound papilla. 
Similarly, percentage coverage of pitting or plaque, or num-
bers of plugs/dilated ducts could be affected by this mor-
phology. For example, a fully compound papilla presumably 
represents the same quantity of renal function as 2 single 
papillae [27], but if it had 5 or more plugs/dilated ducts, we 
scored it a 2 for plugging, which would have increased the 
average plugging score relative to the same number of plugs/
dilated ducts distributed between 2 simple papillae.
Conclusion
Digital endoscopy revealed that kidney stone formers have 
different and distinct papillary morphologies that seem to 
be linked to specific stone-forming pathways. It was evident 
that patients with predominantly ductal plugging differed 
from patients with a high degree of Randall’s plaque. Since 
renal papillary abnormalities may be easily identified during 
endoscopic surgery, this may in the future prove to be an 
important method for tailoring prevention strategies in kid-
ney stone patients.
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